CD248 Antibody (C-term) Blocking Peptide

Catalog Number: ABT-BP6756B
Article Name: CD248 Antibody (C-term) Blocking Peptide
Biozol Catalog Number: ABT-BP6756B
Supplier Catalog Number: BP6756b
Alternative Catalog Number: ABT-BP6756B-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: Endosialin, Tumor endothelial marker 1, CD248, CD248, CD164L1, TEM1
CD248 is believed to play a role in tumor angiogenesis. CD248 is being investigated as a potential target for cancer treatment.
NCBI: 57124
UniProt: Q9HCU0
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP6756b was selected from the C-term region of human CD248. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.